As per Convention on biodiversity (CBD), Biosafety is a term used to describe efforts to reduce and eliminate the potential risk resulting from biotechnology
Potential risks from the use of transgenic crops broadly fall under two categories. 4.1 RISK TO HUMAN HEALTH: Risks to human health are related mainly to toxicity, allergenicity and antibiotic resistance.
There are many biosafety issues with regard to GM foods including toxicity, allergenicity, antibiotic resistance, eating of a foreign DNA, use of promoters of virus origin, changes in nutritional level, gene flow, resistance of target species, impact on biodiversity, ethical issues etc.
With the advancement in the field of agricultural biotechnology, many genetically modified crops like Bt- cotton, Bt- brinjal have been developed and
First Level
Development of a genetically modified crop from a spp. whose center of origin is not that area from where it was produced for which there will be no genetic diversity.
For instance, there will be not a single wild relative present in that specific area.
Least demand of this level is that warranty of monitoring system in that place or area must exis.
Second Level
Development of a genetically modified crop from a spp. whose center of origin is not that area from where it was produced, but there exists its genetic diversity.
For instance, Middle East is the place of origin of wheat, but its wild relative, which is Aegilops cylindrical, exists in Mexico.
In the case of second level of biosafety, there is the p.
Genetically modified wheat is wheat that has been genetically engineered by the direct manipulation of its genome using biotechnology.
As of 2020, no GM wheat is grown commercially, although many field tests have been conducted, with one wheat variety, Bioceres HB4 Wheat, obtaining regulatory approval from the Argentinean government.
